sovietrx beta

cortagen

In the wider archive
formula -
Bioregulator
Khavinson VKh · St. Petersburg Institute of Bioregulation and Gerontology · 2001
cortagen·Bioregulator·Ala-Glu-Asp-Pro
What the corpus says

A four-amino-acid peptide (Ala-Glu-Asp-Pro) developed as a defined-sequence companion to Cortexin. Published literature only. no Russian clinical registration under this exact name.

mechanism confidence: low

PubMed papers
12
in our PubMed map
Russian full-text sources
14
Russian full-text PDFs
Archive notes
4
from archive synthesis
Confidence
low
archive rating
Research synthesis
Mechanism

Synthetic tetrapeptide AEDP (Ala-Glu-Asp-Pro) from the Khavinson school. Mechanism studies (Shabanov-Vislohkov 2013) used intracellular microelectrodes in mollusk Planorbarius corneus pedal ganglia neurons. a classical biophysics model. The pharmacologically meaningful concentration range is 0.1-100 µM, where cortagen HYPERPOLARISES neurons by 2-3 mV and reduces spontaneous impulse activity. i.e. an activating/neuroprotective effect via reduced basal firing (energy conservation). At 1000 µM, mild depolarisation; at 10 mM, strong reversible depolarisation with action-potential suppression. In this assay cortagen is MORE potent than cortexin. Increases slow efflux potassium current amplitude by 3-5% at 0.1 µM. consistent with K⁺ channel opening. The Drosophila study (Mylnikov-Opparina-Malinin 2008) found that mechanisms of vilon and epithalon on mitochondrial ROS differ, implying distinct peptide-specific pathways even within the tetrapeptide class.

Key findings
  1. Mollusk neurons (Planorbarius corneus): cortagen 0.1-100 µM hyperpolarises by 2-3 mV, reduces spontaneous firing (neuroprotective pattern); 1000 µM depolarises mildly; 10 mM strong reversible depolarisation; increases slow K⁺ efflux current 3-5% at 0.1 µM. More potent than cortexin (Shabanov-Vislohkov 2013)
  2. Adjacent (Drosophila): vilon and epithalon have DIFFERENT mechanisms on mitochondrial ROS generation, even though both are tetrapeptides from the same school (Mylnikov 2008)
  3. Adjacent (regulatory peptides review, Boldyreva 2022): short peptides restore protein biosynthesis in age-related decline, used as adjuncts in neurology/dentistry
  4. Cortagen belongs to the same proliferotrope family as Cortagen (tetrapeptide from cortex extract), but as a defined sequence can be studied with clean pharmacology
Evidence quality

grade: Low-moderate. The biophysics work (Shabanov-Vislohkov) is a classical assay but on mollusk neurons. extrapolating to mammalian CNS is reasonable but not proven. No mammalian in vivo pharmacology specific to cortagen has surfaced in CyberLeninka.

Open questions
  • Cortagen as defined sequence is what cortexin ought to be. but cortexin is a polypeptide fraction. Is the AEDP sequence present in cortexin at significant concentration?
  • Mammalian pharmacology of pure AEDP: missing from open literature
  • Why does a defined tetrapeptide show more potent neuronal effects than a fraction? Higher specific activity, or absence of antagonistic peptide components in the fraction?
  • Drosophila data implies multiple distinct mechanisms among tetrapeptides. but which structural features determine the mechanism?

6 Russian sources synthesised · confidence: low

Russian full-text papers (CyberLeninka) · 14

Open-access Russian academic PDFs linked where we have them.

Papers indexed on PubMed

12 total in corpus · top 10 shown

Reviewed against the archive corpora on 2026-09-16. Source-grounded. No clinical claims. Synthesis prose may preserve published experimental context from papers; that is research history, not a recommendation.

← back to the beta landing page